Definitive Contract 75D30123C17565

Award Date 9/1/23
Potential Completion Date 8/31/24
Potential Value $390K
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Galveston, TX 77555, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
189
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $710,772.20 cost-no-fee definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of Texas Medical Branch at Galveston (UTMB) on June 1, 2021. The contract is for FY 21 BAA Topic 8 and has a completion date of October 30, 2022. UTMB is a medical institution that provides a wide range of services to the federal government, including biomedical research, clinical trials, medical training, public health...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to the University of Texas Medical Branch at Galveston (UTMB), a state university system, for medical data translation to English related to a COVID-19 seafood workers study. The contract has a potential value of $265,000.00 and a completion date of May 31, 2023. UTMB is a medical institution that provides a wide range of services to the federal...
This is a federal contract award to the University of Texas Medical Branch at Galveston (UTMB), a major academic health center, for a SETTLEMENT contract with a ceiling value of $518,568.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has no set-aside designation. UTMB, a state-funded educational institution with extensive experience supporting federal agencies, is the prime contractor on this award. The contract provides for the delivery of a variety of goods and...
This federal contract award to the University of Texas Medical Branch at Galveston (UTMB) is for a task order under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The $6,739,837 task order is for the development of medical countermeasures and animal models for biosafety level 4 (BSL-4) pathogens. The work will be performed in Galveston, Texas, and the contract has a final completion date of...
This federal contract award to the University of Texas Medical Branch at Galveston (UTMB) provides a $421,300.00 firm fixed price delivery order from an unspecified U.S. government agency. The contract, which does not have a set-aside designation, is to support a "MANDAY RATE INCREASE" with a period of performance through January 18, 2007. UTMB, a state government entity and educational institution, has extensive experience supporting federal agencies across a range of biomedical...
This is a $1,599,820.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Texas Medical Branch at Galveston (UTMB) to provide SARS-CoV-2 animal models for risk assessment of viral pathogenesis. The contract has a period of performance through February 4, 2024 and was awarded on August 5, 2022. UTMB, a state government educational institution, has extensive experience supporting federal agencies through prime and...
This is a firm fixed price delivery order contract awarded by the Department of the Navy's Bureau of Medicine and Surgery to the University of Texas Medical Branch (UTMB) at Galveston, a state-controlled institution of higher education. The $92,341.01 contract provides tuition and fees for an unspecified purpose, with a period of performance through June 28, 2024. UTMB is a major academic health center that frequently supports federal biomedical and public health initiatives through contracts...
This is a $1,353,918.00 definitive cost-no-fee contract awarded by the Defense Threat Reduction Agency (DTRA) to the University of Texas Medical Branch at Galveston (UTMB), a major academic health center. The contract has no set-aside designation and a performance period ending on June 22, 2020. UTMB, as the prime contractor, will provide a variety of services to DTRA related to biomedical research and healthcare, leveraging its expertise in areas such as infectious disease research, medical...
This $1,468,078.00 grant was awarded by the Shared Services Center, a civilian agency, to the University of Texas Medical Branch at Galveston (UTMB) to conduct research on the "Molecular Characterization of Transmissible Chromosome Aberrations Produced by Ions of Intermediate and High Atomic Number." UTMB, a state government and educational institution, has extensive expertise in biomedical research, including infectious disease studies, vaccine development, and emergency preparedness....
This federal contract award was issued by a U.S. government agency to the University of Texas Medical Branch at Galveston (UTMB), a major academic health center that provides a wide range of medical education, research, and patient care services to the federal government. The $424,982.44 firm fixed-price delivery order does not have a set-aside designation. The contract is likely associated with a larger indefinite delivery contract (IDC) that UTMB holds with the National Institute of Allergy...

The University of Texas Medical Branch at Galveston (UTMB) was awarded a $390,168 Definitive Contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh to conduct work related to Funding Announcement Number FY23 BAA - TOPIC 24. As the prime contractor, UTMB will perform this work in Galveston, Texas from September 1, 2023 through August 31, 2024. The contract pricing type is cost no fee, indicating UTMB will be reimbursed for allowable costs incurred with no potential for fee or profit. No information was provided on any applicable subcontractors.

Generated 11/28/23, 9:27 PM